These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 1345133)

  • 21. Naltrexone vs Placebo for the Treatment of Alcohol Dependence: A Randomized Clinical Trial.
    Oslin DW; Leong SH; Lynch KG; Berrettini W; O'Brien CP; Gordon AJ; Rukstalis M
    JAMA Psychiatry; 2015 May; 72(5):430-7. PubMed ID: 25760804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study).
    Morley KC; Kranzler HR; Luquin N; Baillie A; Shanahan M; Trent R; Teesson M; Haber PS
    Trials; 2018 Aug; 19(1):443. PubMed ID: 30115121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial.
    Heinälä P; Alho H; Kiianmaa K; Lönnqvist J; Kuoppasalmi K; Sinclair JD
    J Clin Psychopharmacol; 2001 Jun; 21(3):287-92. PubMed ID: 11386491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse.
    Chick J; Anton R; Checinski K; Croop R; Drummond DC; Farmer R; Labriola D; Marshall J; Moncrieff J; Morgan MY; Peters T; Ritson B
    Alcohol Alcohol; 2000; 35(6):587-93. PubMed ID: 11093966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of naltrexone on alcohol and cocaine use in dually addicted patients.
    Oslin DW; Pettinati HM; Volpicelli JR; Wolf AL; Kampman KM; O'Brien CP
    J Subst Abuse Treat; 1999 Mar; 16(2):163-7. PubMed ID: 10023615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence.
    Balldin J; Berglund M; Borg S; Månsson M; Bendtsen P; Franck J; Gustafsson L; Halldin J; Nilsson LH; Stolt G; Willander A
    Alcohol Clin Exp Res; 2003 Jul; 27(7):1142-9. PubMed ID: 12878920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders.
    Petrakis IL; Poling J; Levinson C; Nich C; Carroll K; Rounsaville B;
    Biol Psychiatry; 2005 May; 57(10):1128-37. PubMed ID: 15866552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence.
    O'Malley SS; Jaffe AJ; Chang G; Rode S; Schottenfeld R; Meyer RE; Rounsaville B
    Arch Gen Psychiatry; 1996 Mar; 53(3):217-24. PubMed ID: 8611058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted nalmefene with simple medical management in the treatment of heavy drinkers: a randomized double-blind placebo-controlled multicenter study.
    Karhuvaara S; Simojoki K; Virta A; Rosberg M; Löyttyniemi E; Nurminen T; Kallio A; Mäkelä R
    Alcohol Clin Exp Res; 2007 Jul; 31(7):1179-87. PubMed ID: 17451401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naltrexone combined with either cognitive behavioral or motivational enhancement therapy for alcohol dependence.
    Anton RF; Moak DH; Latham P; Waid LR; Myrick H; Voronin K; Thevos A; Wang W; Woolson R
    J Clin Psychopharmacol; 2005 Aug; 25(4):349-57. PubMed ID: 16012278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of compliance with naltrexone among alcoholics.
    Rohsenow DJ; Colby SM; Monti PM; Swift RM; Martin RA; Mueller TI; Gordon A; Eaton CA
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1542-9. PubMed ID: 11045863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of concurrent alcohol use disorder and pathological gambling.
    Toneatto T; Brands B; Selby P
    Am J Addict; 2009; 18(3):219-25. PubMed ID: 19340640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Ray LA; Hutchison KE
    Arch Gen Psychiatry; 2007 Sep; 64(9):1069-77. PubMed ID: 17768272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
    O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
    J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
    Brown ES; Carmody TJ; Schmitz JM; Caetano R; Adinoff B; Swann AC; John Rush A
    Alcohol Clin Exp Res; 2009 Nov; 33(11):1863-9. PubMed ID: 19673746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical management of alcohol dependence: clinical use and limitations of naltrexone treatment.
    Volpicelli JR; Volpicelli LA; O'Brien CP
    Alcohol Alcohol; 1995 Nov; 30(6):789-98. PubMed ID: 8679021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nalmefene. Alcohol dependence: no advance.
    Prescrire Int; 2014 Jun; 23(150):150-2. PubMed ID: 25121147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient cognitive behavioural therapy programme for alcohol dependence: impact of naltrexone use on outcome.
    Feeney GF; Young RM; Connor JP; Tucker J; McPherson A
    Aust N Z J Psychiatry; 2001 Aug; 35(4):443-8. PubMed ID: 11531723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence.
    Mason BJ; Salvato FR; Williams LD; Ritvo EC; Cutler RB
    Arch Gen Psychiatry; 1999 Aug; 56(8):719-24. PubMed ID: 10435606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.